Cell Biology

E.A. Wayner, A. Garcia-Pardo, M.J. Humphries, J.A. McDonald, W.G. Carter, "Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin," The Journal of Cell Biology, 109, 1321-30, September 1989. Elizabeth A. Wayner (Cytel Corp., La Jolla, Calif.): "It was originally thought that the adhesion of mesenchymal cells to fibronectin was solely determined by the interaction of the integrin receptor, a5b1, with the ce

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

E.A. Wayner, A. Garcia-Pardo, M.J. Humphries, J.A. McDonald, W.G. Carter, "Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin," The Journal of Cell Biology, 109, 1321-30, September 1989.

Elizabeth A. Wayner (Cytel Corp., La Jolla, Calif.): "It was originally thought that the adhesion of mesenchymal cells to fibronectin was solely determined by the interaction of the integrin receptor, a5b1, with the central cell binding domain that contains RGD [a specific adhesion sequence]. Our study was the first to identify the RGD-independent fibronectin receptor present on lymphocytes, integrin a4b1. Instead of RGD, this receptor recognizes an amino acid sequence (CS-1) located within the alternatively spliced, or V (for variable), region of fibronectin. Thus, lymphocyte adhesion to fibronectin involves at least two independent receptor-ligand interactions: a5b1 to RGD, and a4b1 to CS-1. These studies allowed us to identify the alternative adhesion sequence, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies